Englander Institute for Precision Medicine

Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites.

TitleDeciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites.
Publication TypeJournal Article
Year of Publication2025
AuthorsJiang W, Jaehnig EJ, Liao Y, Shi Z, Yaron-Barir TM, Johnson JL, Cantley LC, Zhang B
JournalNat Commun
Volume16
Issue1
Pagination2766
Date Published2025 Mar 20
ISSN2041-1723
KeywordsHumans, Machine Learning, Mass Spectrometry, Neoplasms, Phosphoproteins, Phosphorylation, Protein Serine-Threonine Kinases, Proteome, Proteomics, Signal Transduction, Substrate Specificity
Abstract

Mass spectrometry-based phosphoproteomics offers a comprehensive view of protein phosphorylation, yet our limited knowledge about the regulation and function of most phosphosites hampers the extraction of meaningful biological insights. To address this challenge, we integrate machine learning with phosphoproteomic data from 1195 tumor specimens spanning 11 cancer types to construct CoPheeMap, a network that maps the co-regulation of 26,280 phosphosites. By incorporating network features from CoPheeMap into a second machine learning model, namely CoPheeKSA, we achieve superior performance in predicting kinase-substrate associations. CoPheeKSA uncovers 24,015 associations between 9399 phosphosites and 104 serine/threonine kinases, shedding light on many unannotated phosphosites and understudied kinases. We validate the accuracy of these predictions using experimentally determined kinase-substrate specificities. Through the application of CoPheeMap and CoPheeKSA to phosphosites with high computationally predicted functional significance and those associated with cancer, we demonstrate their effectiveness in systematically elucidating phosphosites of interest. These analyses unveil dysregulated signaling processes in human cancer and identify understudied kinases as potential therapeutic targets.

DOI10.1038/s41467-025-57993-2
Alternate JournalNat Commun
PubMed ID40113755
PubMed Central IDPMC11926083
Grant ListR01 CA245903 / CA / NCI NIH HHS / United States
U24 CA271076 / CA / NCI NIH HHS / United States
U24 CA271076, R01 CA245903, U01 CA271247 / / U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) /
RP210027 / / Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) /
RP220050 / / Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) /
U01 CA271247 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021